BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19636172)

  • 1. Anxiety levels and related pharmacological drug treatment: a memorandum for the third millennium.
    Pasquini M; Berardelli I
    Ann Ist Super Sanita; 2009; 45(2):193-204. PubMed ID: 19636172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of anxious disorders.
    Bourin M; Lambert O
    Hum Psychopharmacol; 2002 Dec; 17(8):383-400. PubMed ID: 12457374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent perspectives on the diagnosis and treatment of generalized anxiety disorder.
    Ninan PT
    Am J Manag Care; 2001 Sep; 7(11 Suppl):S367-76. PubMed ID: 11570027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety and OCD - the chicken or the egg?
    Nutt D; Malizia A
    J Psychopharmacol; 2006 Nov; 20(6):729-31. PubMed ID: 17060345
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug treatment of obsessive-compulsive disorder: a review of findings in the light of diagnostic and metric limitations.
    Towbin KE; Leckman JF; Cohen DJ
    Psychiatr Dev; 1987; 5(1):25-50. PubMed ID: 2885832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of brain imaging in anxiety disorders.
    Damsa C; Kosel M; Moussally J
    Curr Opin Psychiatry; 2009 Jan; 22(1):96-110. PubMed ID: 19122541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of the relation of intolerance of uncertainty to symptoms of generalized anxiety disorder, major depressive disorder, and obsessive-compulsive disorder.
    Gentes EL; Ruscio AM
    Clin Psychol Rev; 2011 Aug; 31(6):923-33. PubMed ID: 21664339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence.
    Mula M; Pini S; Cassano GB
    J Clin Psychopharmacol; 2007 Jun; 27(3):263-72. PubMed ID: 17502773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized anxiety disorder: A comorbid disease.
    Nutt D; Argyropoulos S; Hood S; Potokar J
    Eur Neuropsychopharmacol; 2006 Jul; 16 Suppl 2():S109-18. PubMed ID: 16737802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let's talk facts about anxiety disorders.
    American Psychiatric Association
    J Okla State Med Assoc; 2008 Dec; 101(12):347-50. PubMed ID: 19177997
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurostimulation in Anxiety Disorders, Post-traumatic Stress Disorder, and Obsessive-Compulsive Disorder.
    Freire RC; Cabrera-Abreu C; Milev R
    Adv Exp Med Biol; 2020; 1191():331-346. PubMed ID: 32002936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the understanding and treatment of anxiety disorders.
    Shearer SL
    Prim Care; 2007 Sep; 34(3):475-504, v-vi. PubMed ID: 17868756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjustment disorders and anxiety disorders].
    Gohier B; Chocard AS; Duverger P; Garré JB
    Rev Prat; 2007 Nov; 57(18):2061-6. PubMed ID: 18326442
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.
    Baldwin DS; Anderson IM; Nutt DJ; Allgulander C; Bandelow B; den Boer JA; Christmas DM; Davies S; Fineberg N; Lidbetter N; Malizia A; McCrone P; Nabarro D; O'Neill C; Scott J; van der Wee N; Wittchen HU
    J Psychopharmacol; 2014 May; 28(5):403-39. PubMed ID: 24713617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of anxiety syndrome. A systematic literature review. Summary and conclusions by the SBU].
    von Knorring L; Thelander S; Pettersson A
    Lakartidningen; 2005 Nov 21-27; 102(47):3561-2, 3565-6, 3569. PubMed ID: 16408394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory modification as an outcome variable in anxiety disorder treatment.
    Tryon WW; McKay D
    J Anxiety Disord; 2009 May; 23(4):546-56. PubMed ID: 19117720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of benzodiazepine use in a transdiagnostic sample of panic disorder, social anxiety disorder, and obsessive-compulsive disorder patients.
    Laurito LD; Loureiro CP; Dias RV; Vigne P; de Menezes GB; Freire RC; Stangier U; Fontenelle LF
    Psychiatry Res; 2018 Apr; 262():237-245. PubMed ID: 29475102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diazepam use during pregnancy: a review of the literature.
    Iqbal MM; Sobhan T; Aftab SR; Mahmud SZ
    Del Med J; 2002 Mar; 74(3):127-35. PubMed ID: 11963349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural remedies for anxiety disorders: potential use and clinical applications.
    Kinrys G; Coleman E; Rothstein E
    Depress Anxiety; 2009; 26(3):259-65. PubMed ID: 19123457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new explanatory model for obsessive-compulsive disorder].
    Visser HA; van Megen HJ; van Oppen P; van Balkom AJ
    Tijdschr Psychiatr; 2009; 51(4):227-37. PubMed ID: 19434577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.